TickerFacts.

Filana Therapeutics, Inc. (FLNA): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$32.83M
Year ended 2025-12-31
2014-12-31: -$9.63M2015-12-31: -$9.25M2016-12-31: -$12.31M2019-12-31: -$2.53M2021-12-31: -$52.41M2022-12-31: -$80.23M2023-12-31: -$82.44M2024-12-31: -$117.03M2025-12-31: -$32.83M-$32.83M
2014-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$32.83Mn/m2026-03-12, From 2025-01-01
2024-12-31-$117.03Mn/m2026-03-12, From 2024-01-01
2023-12-31-$82.44Mn/m2026-03-12, From 2023-01-01
2022-12-31-$80.23Mn/m2025-03-03, From 2022-01-01
2021-12-31-$52.41Mn/a2024-02-28, From 2021-01-01
No annual figure between 2019-12-31 and 2021-12-31.
2019-12-31-$2.53Mn/a2021-03-23, From 2019-01-01
No annual figure between 2016-12-31 and 2019-12-31.
2016-12-31-$12.31Mn/m2018-02-06, From 2016-01-01
2015-12-31-$9.25Mn/m2017-03-07, From 2015-01-01
2014-12-31-$9.63Mn/a2017-03-07, From 2014-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Filana Therapeutics, Inc. (FLNA)2025-12-31-$32.83Mn/m
Camp4 Therapeutics Corp (CAMP)2025-12-31-$29.83Mn/m
Aardvark Therapeutics, Inc. (AARD)2025-12-31-$54.27Mn/m
Kyntra Bio, Inc. (KYNB)2025-12-31-$4.81Mn/m
PMV Pharmaceuticals, Inc. (PMVP)2025-12-31-$73.61Mn/m
Rafael Holdings, Inc. (RFL)2025-07-31-$18.93Mn/m
Milestone Pharmaceuticals Inc. (MIST)2025-12-31-$49.34Mn/m
Korro Bio, Inc. (KRRO)2025-12-31-$79.08Mn/m
Zomedica Corp. (ZOMDF)2025-12-31-$18.22Mn/m

Compare FLNA, CAMP, AARD, KYNB side by side · Screen every company in Pharmaceutical Preparations ↗